Bayer's Trasylol Increases Risk Of Death: Study
The final results of the long-awaited study, published last Thursday in the New England Journal of Medicine, showed that Trasylol increases the risk of death by 54% while also greatly increasing the risk of other heart complications.
Bayer suspended sales of Trasylol in November at the urging of the U.S....
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login